Investigation on the Possibility of Biowaivers for Ibuprofen
- 1 June 2011
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 100 (6) , 2343-2349
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Bioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteersBMC Clinical Pharmacology, 2009
- Summary Workshop Report: Bioequivalence, Biopharmaceutics Classification System, and BeyondThe AAPS Journal, 2008
- Ibuprofen sodium dihydrate, an ibuprofen formulation with improved absorption characteristics, provides faster and greater pain relief than ibuprofen acidInt. Journal of Clinical Pharmacology and Therapeutics, 2007
- Feasibility of Biowaiver Extension to Biopharmaceutics Classification System Class III Drug ProductsClinical Pharmacokinetics, 2006
- Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ibuprofen**This paper reflects the scientific opinion of the authors and not the policies of regulating agencies.Journal of Pharmaceutical Sciences, 2005
- Biowaiver monographs for immediate release solid oral dosage forms: Ranitidine hydrochlorideJournal of Pharmaceutical Sciences, 2005
- Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification systemEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Summary workshop report: Biopharmaceutics classification system—implementation challenges and extension opportunitiesJournal of Pharmaceutical Sciences, 2004
- Ibuprofen arginate provides effective relief from postoperative dental pain with a more rapid onset of action than ibuprofenEuropean Journal of Clinical Pharmacology, 2002
- Comparative human study of ibuprofen enantiomer plasma concentrations produced by two commercially available ibuprofen tabletsBiopharmaceutics & Drug Disposition, 1988